Homepage

Nutex Health, Inc.

NUTX NASDAQ Categories PDF
Healthcare · Medical - Healthcare Information Services · United States · Updated May 10, 6:34pm
$136.66
Price
$813.7M
Market Cap
800
Employees
2.07
Beta
Thomas T. Vo
CEO
Business Description

Nutex Health, Inc. operates as a technology-enabled healthcare services company. It operates through two divisions: Hospital division and Population Health Management division. The Hospital division implements and operates health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments. This division owns and operates 21 facilities in 8 states. The Population Health Management division owns and operates provider networks, such as independent physician associations. Its management services organizations provide management, administrative, and other support services to its affiliated hospitals and physician groups. This division's cloud-based proprietary technology platform aggregates data across multiple information systems, settings, and sources to create a holistic view of each patient and provider, as well as allows to deliver care. The company is based in Houston, Texas.

Business History
Price Overview
Last updated: May 11, 2026 1:55pm (just now)
$134.25
-2.41 (-1.76%)
Day Range
$133.89 – $140.15
52-Week Range
$77.21 – $193.07
50-Day MA
$105.86
200-Day MA
$117.26
Volume
87,120.84
Analyst Price Targets
Low $205.00
Consensus $205.00
High $205.00
(2 analysts)
Share Structure
Outstanding 5,954,326.00
Float 2,943,985.00
Free Float 49.4%
Moderate free float — 49.4% of shares trade freely, ~50.6% held by insiders/institutions
Reasonable but insiders still hold a significant stake. This can be positive (skin in the game) but may limit liquidity during sell-offs.
Small absolute float (2.9M shares) — even with a decent free float %, volume can be thin. Check average daily volume before sizing a position.
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
Period Revenue Net Income Net Margin YoY/QoQ
Key Metrics
API Direct from provider CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
API
Stock Price / EPS (Diluted)
9.33
Stock Price: $136.66
EPS (Diluted): 11.13
P/B Ratio (Price vs net asset value)
API
Stock Price / Book Value Per Share
3.18
Stock Price: $136.66
Total Equity: $329.45M
Shares: 6,756,108
EV/EBITDA (Total value vs operating profit)
API
Enterprise Value / EBITDA
3.22
Market Cap: $813.72M
Total Debt: $43.25M
Cash: $185.57M
EBITDA: $287.54M
Enterprise Value (Takeover price (cap + debt - cash))
API
Market Cap + Total Debt - Cash
$1.2B
Market Cap: $813.72M
Total Debt: $43.25M
Cash: $185.57M
Gross Margin (Revenue left after direct costs)
API
Gross Profit / Revenue
50.8%
Gross Profit: $444.28M
Revenue: $875.26M
Operating Margin (Revenue left after all operations)
API
Operating Income / Revenue
31.5%
Operating Income: $275.63M
Revenue: $875.26M
Net Margin (Revenue left as actual profit)
API
Net Income / Revenue
8.1%
Net Income: $70.79M
Revenue: $875.26M
ROE (Profit from shareholder equity)
API
Net Income / Total Equity
31.4%
Net Income: $70.79M
Total Equity: $329.45M
ROIC (Profit from all invested capital)
API
NOPAT / Invested Capital
26.6%
Operating Income: $275.63M
Tax Rate: 26.3%
Equity: $329.45M
Total Debt: $43.25M
Cash: $185.57M
Current Ratio (Can it pay short-term bills)
API
Current Assets / Current Liabilities
3.41
Current Assets: $538.81M
Current Liabilities: $157.91M
Debt/Equity (Leverage — debt vs equity)
CALC
Total Debt / Total Equity
0.13
Short-Term Debt: $14.08M
Long-Term Debt: $29.17M
Total Debt: $43.25M
Total Equity: $329.45M
Rev/Share (Top-line per share)
CALC
Revenue / Shares Outstanding
$129.55
Revenue: $875.26M
Shares: 6,756,108
Book Value/Share (Net assets per share)
CALC
(Total Assets - Total Liabilities) / Shares
$48.76
Total Equity: $329.45M
Shares: 6,756,108
FCF/Share (Real cash generated per share)
CALC
(Operating Cash Flow + CapEx) / Shares
$36.35
Operating CF: $248.13M
CapEx: -$2.53M
Shares: 6,756,108
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
API
Last Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $136.66
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: $70.79M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares NUTX against LLM-researched typical ranges for its industry. One research call per industry, cached indefinitely — every stock in the same industry reuses the same baseline.
Deep Analysis

Pre-flight intelligence scans the company first, then routes to the right analytical methods.

0 Company Classification — What type of company is this?
1 Industry Landscape — Where is the industry headed?
2 Company Momentum — Where is this company trending?
3 Forward Projection — 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a DCF Valuation — Present value of future cash flows
4b Earnings Power Value — Floor value — worth with zero growth
4c Anchored PE — Industry PE adjusted for growth differential
4d Reverse DCF — What growth is the market pricing in?
4e Revenue-Based DCF — For growth/narrative companies (skip if mature earner)
4f Anchored P/S — Price-to-Sales peer comparison (skip if mature earner)
4g Scenario Analysis — Bull / Base / Bear (skip if mature earner)
4h Dividend Discount Model — For dividend/income stocks only
4i Book Value Analysis — For deep value / turnaround stocks only
4j Insider Activity — Are insiders buying or selling?
4f Cash Flow Quality — How trustworthy is the FCF?
4g Debt Maturity Risk — Can it handle its debt?
4h Macro Environment — Rates, market valuation, volatility
4i Sector Intelligence — How does this company compare within its sector?
4j Revenue Confidence — How reliable is the growth projection?
4k Sensitivity Analysis — How fragile is the fair value estimate?
4l Sector Demand Cycle — Is the sector in a boom, steady state, or contraction?
5 AI Investigation — Adaptive research engine (Claude)
5b Thesis Evaluation — What does the market believe? (narrative/platform stocks only)
6 Valuation Synthesis — Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Metric 2021 2022 2023 2024 2025
Revenue $331.5M $219.3M $247.6M $479.9M $875.3M
Cost of Revenue $152.3M $203.9M $212.9M $283.7M $431.0M
Gross Profit $179.3M $15.4M $34.8M $196.3M $444.3M
Operating Expenses $9.0M $422.0M $66.5M $65.6M $168.7M
Operating Income $170.3M -$406.6M -$31.8M $130.6M $275.6M
Net Income $132.6M -$424.8M -$45.8M $52.2M $70.8M
EBITDA $183.4M -$394.0M -$14.6M $148.7M $287.5M
EPS $33.55 $-100.50 $-10.39 $10.23 $11.13
EPS (Diluted) — — — — —
Balance Sheet (Annual)
Metric 2021 2022 2023 2024 2025
Cash & Equivalents $36.1M $34.3M $22.0M $43.6M $185.6M
Total Current Assets $154.0M $98.0M $90.8M $292.5M $538.8M
Total Assets $394.7M $431.8M $398.2M $655.3M $918.5M
Current Liabilities $37.7M $54.9M $58.3M $140.9M $157.9M
Long-Term Debt $78.8M $23.1M $26.3M $22.5M $29.2M
Total Liabilities $203.1M $311.4M $319.1M $453.4M $495.1M
Total Equity $114.7M $95.9M $61.5M $146.3M $329.4M
Retained Earnings $102.3M -$363.3M -$409.1M -$356.9M -$286.2M
Cash Flow (Annual)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $173.4M $50.6M $1.3M $23.2M $248.1M
Capital Expenditure -$36.9M -$14.6M -$9.5M -$2.3M -$2.5M
Free Cash Flow $136.5M $36.0M -$8.2M $20.8M $245.6M
Acquisitions (net) $-48,853 $10.3M -$1.7M $-361,325 $0
Debt Repayment — — — — —
Dividends Paid — — — — —
Stock Buybacks $0 $0 $0 $0 -$5.0M
Net Change in Cash $10.6M -$1.9M -$12.3M $21.6M $144.9M
Analyst Estimates (Annual)
Metric 2024 2025 2026 2027
Revenue $303.5M
$296.8M – $313.1M
 $982.4M
$964.3M – $994.0M
 $883.0M
$865.0M – $908.7M
 $972.2M
$949.3M – $1.0B
EBITDA $8.1M
$7.9M – $8.3M
 $26.1M
$25.6M – $26.4M
 $23.4M
$23.0M – $24.1M
 $25.8M
$25.2M – $26.7M
Net Income -$13.8M
-$14.2M – -$13.3M
 $96.4M
$92.3M – $99.0M
 $155.1M
$102.7M – $164.6M
 $148.6M
$124.4M – $172.8M
EPS — — — —
Growth Trends (YoY %)
Metric 2022 2023 2024 2025
Revenue Growth -33.9% +12.9% +93.8% +82.4%
Gross Profit Growth -91.4% +125.5% +464.4% +126.4%
Operating Income Growth -338.8% +92.2% +511.1% +111.0%
Net Income Growth -420.4% +89.2% +214.0% +35.7%
EBITDA Growth -314.8% +96.3% +1,119.5% +93.4%
Insider Trading (Recent)
Date Insider Type Shares Price Value
2026-04-23 Reed Michael Lee A-Award 823.00 $0.00 $0
2026-04-23 Saunders Scott J A-Award 823.00 $0.00 $0
2026-04-23 Jaumot Frank E A-Award 823.00 $0.00 $0
2026-04-23 Grenas Cheryl Yvonne A-Award 823.00 $0.00 $0
2026-04-09 Vo Thomas T. J-Other 184,071.00 $0.00 $0
2026-03-10 Vo Thomas T. M-Exempt 4,841.00 $0.00 $0
2026-03-11 Bamburg Wesley Shane M-Exempt 2,411.00 $0.00 $0
2026-03-10 Hosseinion Warren M-Exempt 3,656.00 $0.00 $0
2026-03-19 Hosseinion Warren P-Purchase 252.00 $94.07 $23,706
2026-03-20 Jaumot Frank E P-Purchase 150.00 $93.56 $14,033
2026-03-17 Spears Kelvin P-Purchase 10.00 $94.46 $945
2026-03-10 Spears Kelvin M-Exempt 116.00 $0.00 $0
2026-03-10 Montgomery Pamela W. M-Exempt 1,523.00 $0.00 $0
2026-03-13 Montgomery Pamela W. P-Purchase 79.00 $88.87 $7,021
2026-03-10 Luqman Elisa V M-Exempt 1,525.00 $0.00 $0
2026-03-10 Luqman Elisa V M-Exempt 2,084.00 $0.00 $0
2026-03-10 Luqman Elisa V F-InKind 784.00 $86.22 $67,598
2026-03-10 Montgomery Pamela W. M-Exempt 1,525.00 $0.00 $0
2026-03-10 Montgomery Pamela W. M-Exempt 2,084.00 $0.00 $0
2026-03-10 Montgomery Pamela W. F-InKind 776.00 $86.22 $66,909
Community AI Feedback
Sign in to Contribute
No community reviews yet for NUTX. Be the first — export the analysis to your AI and contribute back.
My Notes personal — only you see this
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.193 · 1946f027 · 2026-05-08 18:57:27